Back to Search
Start Over
[Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
- Source :
-
Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2005 Dec; Vol. 63 Suppl 12, pp. 450-3. - Publication Year :
- 2005
- Subjects :
- 2-Pyridinylmethylsulfinylbenzimidazoles
Amoxicillin pharmacokinetics
Anti-Bacterial Agents pharmacokinetics
Cytochrome P-450 CYP2C19
Drug Therapy, Combination
Enzyme Inhibitors pharmacokinetics
Humans
Lansoprazole
Omeprazole administration & dosage
Omeprazole pharmacokinetics
Pharmacogenetics
Polymorphism, Genetic
Proton Pump Inhibitors
Treatment Failure
Amoxicillin administration & dosage
Anti-Bacterial Agents administration & dosage
Aryl Hydrocarbon Hydroxylases genetics
Enzyme Inhibitors administration & dosage
Genotype
Helicobacter Infections drug therapy
Helicobacter pylori
Mixed Function Oxygenases genetics
Omeprazole analogs & derivatives
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0047-1852
- Volume :
- 63 Suppl 12
- Database :
- MEDLINE
- Journal :
- Nihon rinsho. Japanese journal of clinical medicine
- Publication Type :
- Academic Journal
- Accession number :
- 16416832